/Companies

Curelab Veterinary

Dedham, US · Founded 2020 · Delaware corporation

Find your way into Curelab Veterinary

25 people in our graph share verified history with the Curelab Veterinary team — schools, employers, funds. One of them is your warm intro.

David Sinclairunlockedknows Alexander Shneider · together at Aging (overlapped)
×2knows the team · via Gen3 Partners (at the moment, Invention Machine, Inc.)
×2knows the team · via Boston University School of Public Health
×7knows the team · via Roskilde University

CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.

Founders & leadership

Curelab Veterinary was founded in 2020 by Alexander Shneider.

ASAlexander Shneider
Alexander ShneiderFounder, Chairman of the Board, Interim CEOAlexander Shneider is a biotech entrepreneur with over two decades of experience in industry roles including consulting and advisory positions for biotech and pharmaceutical companies on R&D, technology transfer, and business strategy; he also held academic positions and serves on scientific journal editorial boards. He founded Curelab Veterinary, which develops gene therapy treatments for cancer and inflammatory conditions in animals.
RDRobert Devlin
Robert DevlinPresident
ANAlexis Nahama
Alexis NahamaExecutive Vice-President, Business Development & Licensing
VGVlad Gabai
Vlad GabaiVP of R&D
SSStephen Spector
Stephen SpectorVP of Strategic BD
JP
Jason PayneNamed on SEC filing
TO
Trevor OlsenController
FV
Franco VenanziDirector of Basic Research
IL
Ilya LapshinLegal Counsel

Reported raises · per SEC filings

Form D private placements

$2.5M disclosed across 1 round · 2022

▶$2.5MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason PayneExecutive Officer
  • Alex ShneiderExecutive Officer
  • Robert DevlinExecutive Officer
Offering amount
$2.5M
Amount sold
$2.5M
Minimum investment
$10K
Proceeds to insiders
$200K
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Curelab Veterinary for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Curelab Veterinary do?
CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.
Who founded Curelab Veterinary?
Curelab Veterinary was founded by Alexander Shneider in 2020.
How much funding has Curelab Veterinary raised?
Curelab Veterinary has disclosed $2.5M raised across 1 round.
Where is Curelab Veterinary headquartered?
Curelab Veterinary is headquartered in Dedham, US.